The competitive landscape of the antibody sector in 2025 is defined by a strategic transition from "Broad-Spectrum" to "Targeted Precision." A recent Antibodies Market Share analysis highlights the dominance of a "Big Pharma" group including F. Hoffmann-La Roche, AbbVie, Johnson & Johnson, and Merck KGaA. These organizations maintain their lead through "Portfolio Diversification," bundling...